We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOTS
13251
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$11K ﹤0.01%
104
-493
-83% -$57.5K
NAACW
13252
DELISTED
North Atlantic Acquisition Corporation Warrant
NAACW
$11K ﹤0.01%
32,388
-100
-0.3% -$44
EVFM
13253
PUT
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$11K ﹤0.01%
2,200
-1,567
-42% -$9.86K
NAVB
13254
PUT
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$11K ﹤0.01%
14,100
-21,700
-61% -$19.9K
ENVB icon
13255
PUT
Enveric Biosciences
ENVB
$6.24M
$10K ﹤0.01%
3
-2
-40% -$8.84K
IGC icon
13256
IGC Pharma
IGC
$26.8M
$10K ﹤0.01%
10,007
-46,789
-82% -$45.4K
MBIO icon
13257
PUT
Mustang Bio
MBIO
$4.55M
$10K ﹤0.01%
14
-20
-59% -$16.4K
FATH.WS
13258
DELISTED
Fathom Digital Manufacturing Corporation Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50 per share
FATH.WS
$10K ﹤0.01%
13,473
-188,316
-93% -$175K
ASAXW
13259
DELISTED
Astrea Acquisition Corp. Warrant
ASAXW
$10K ﹤0.01%
49,560
+802
+2% +$267
AMPE
13260
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$10K ﹤0.01%
73
-490
-87% -$71.6K
RNWK
13261
PUT
DELISTED
RealNetworks Inc
RNWK
$10K ﹤0.01%
16,400
-15,800
-49% -$11.5K
PME
13262
DELISTED
Pingtan Marine Enterprise Ltd.
PME
$10K ﹤0.01%
+15,266
New +$9.6K
CNET icon
13263
PUT
ZW Data Action Technologies
CNET
$5.1M
$9K ﹤0.01%
585
-220
-27% -$3.38K
MRKR icon
13264
CALL
Marker Therapeutics
MRKR
$18.7M
$9K ﹤0.01%
2,130
-7,230
-77% -$41.3K
NAAS
13265
CALL
NaaS Technology Inc
NAAS
$59M
$9K ﹤0.01%
+1
New +$5.16K
RMTI icon
13266
Rockwell Medical
RMTI
$28.2M
$9K ﹤0.01%
175
-196
-53% -$8.3K
SABSW icon
13267
SAB Biotherapeutics Warrant
SABSW
$104K
$9K ﹤0.01%
19,487
-141
-0.7% -$119
TXMD icon
13268
PUT
TherapeuticsMD
TXMD
$24M
$9K ﹤0.01%
480
-1,582
-77% -$24.9K
RDGT
13269
Ridgetech Inc
RDGT
$2.71M
$9K ﹤0.01%
+1
New +$12.5K
KRBP
13270
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$9K ﹤0.01%
356
-1,088
-75% -$32.2K
SECO
13271
CALL
DELISTED
Secoo Holding Limited ADR
SECO
$9K ﹤0.01%
2,570
-4,350
-63% -$16.7K
TINV.WS
13272
DELISTED
Tiga Acquisition Corp. Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TINV.WS
$9K ﹤0.01%
23,224
-148,462
-86% -$74.9K
TYME
13273
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$9K ﹤0.01%
25,969
+7,261
+39% +$2.9K
ALNA
13274
DELISTED
Allena Pharmaceuticals
ALNA
$9K ﹤0.01%
37,613
+7,788
+26% +$3.23K
SRGA
13275
CALL
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$9K ﹤0.01%
+990
New +$15K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.